BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 279 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2021. The put-call ratio across all filers is 1.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $6,320 | +40.5% | 100 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $4,499 | +2.7% | 100 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $4,381 | -37.4% | 100 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $7,000 | +40.0% | 100 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $5,000 | -16.7% | 100 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $6,000 | -45.5% | 100 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $11,000 | +10.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $10,000 | +11.1% | 100 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $9,000 | -10.0% | 100 | 0.0% | 0.00% | -33.3% |
| Q1 2021 | $10,000 | -9.1% | 100 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $11,000 | +22.2% | 100 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $9,000 | +12.5% | 100 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $8,000 | 0.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $8,000 | 0.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $8,000 | +14.3% | 100 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $7,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 559,381 | $41,098,000 | 15.69% |
| Casdin Capital, LLC | 940,000 | $69,061,800,000 | 7.15% |
| Ghost Tree Capital, LLC | 325,000 | $23,878,000 | 6.08% |
| CADIAN CAPITAL MANAGEMENT, LP | 1,418,704 | $104,232,000 | 4.96% |
| DAFNA Capital Management LLC | 123,218 | $9,053,000 | 3.40% |
| BVF INC/IL | 437,565 | $32,148,000 | 3.38% |
| Opaleye Management Inc. | 105,000 | $7,714,000 | 2.79% |
| Cormorant Asset Management, LP | 493,000 | $36,221,000 | 2.20% |
| Novo Holdings A/S | 170,667 | $12,539,000 | 2.15% |
| Artal Group S.A. | 600,000 | $44,082,000 | 1.77% |